FLORENCE — HopeHealth is participating in a phase 3 clinical research study, sponsored by global pharmaceutical company Bristol Myers Squibb, to evaluate an investigational treatment in patients with systemic lupus erythematosus. SLE is a chronic autoimmune disease in which the…

See Full Page